Asia Pacific Gastroenterology Cancer Summit shared on LinkedIn:
“How are new treatment pathways reshaping the future of gastric and liver cancer care?
At APGCS 2025, we’re bringing clinical innovation to the forefront in Session 2: Esophageal and Gastric Cancers – Innovations, Insights and Impact.
1st August 2025 | 10:45 – 13:45 SGT
- Advancements and Future Directions in Metastatic HER2-Positive Gastric Cancer
- What’s New in the Perioperative Management of Gastric Cancer
- Panel Discussion: Beyond the Algorithm – Personalizing Systemic Therapy in Intermediate-Advanced HCC
Whether you treat gastric or hepatocellular carcinoma, this is your chance to engage with regionally focused, expert-driven discussions designed to improve patient outcomes.
Register today to be part of the conversation.”